ARS Pharmaceuticals
SPRY
#7264
Rank
ยฃ0.43 B
Marketcap
ยฃ4.33
Share price
-3.03%
Change (1 day)
-68.45%
Change (1 year)

Revenue for ARS Pharmaceuticals (SPRY)

Revenue in 2026 (TTM): ยฃ73.6 Million

According to ARS Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ74.47 Million. In 2025 the company made a revenue of ยฃ62.58 Million a decrease over the revenue in the year 2024 that were of ยฃ71.04 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ARS Pharmaceuticals from 2022 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ73.6 M17.62%
2025 ยฃ62.58 M-11.91%
2024 ยฃ71.04 M301584.03%
2023 ยฃ0.02 M-97.84%
2022 ยฃ1.08 M